PTCA Drug Coated Balloon (DCB) Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Report Overview

A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug-coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries. DCB Catheters provide fast, short-term, homogenous, local drug delivery. DCB catheters preserve the anatomy of the vessel, promote enhanced vessel healing, and reduce the need for prolonged dual anti-platelet therapy without leaving any metal behind.

The PTCA DCB pipeline market report provides comprehensive information about the PTCA Drug Coated Balloon (DCB) Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

PTCA DCB Pipeline Market Segmentation by Territories

The key territories in the PTCA DCB pipeline market are the US, China, Japan, Europe, and Dominican Republic. As of April 2023, the US has the highest number of pipeline products.

PTCA DCB Pipeline Market Analysis, by Territories, 2023 (%)

PTA DCB Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the PTCA DCB pipeline market, download a free report sample

PTCA DCB Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the PTCA DCB pipeline market are NMPA, PMA, Shonin, 510(k), CE, and de novo. As of April 2023, NMPA is the most followed pathway for pipeline products.

PTCA DCB Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

PTA DCB Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the PTCA DCB pipeline market, download a free report sample

PTCA DCB Pipeline Market – Competitive Landscape

Some of the key companies in the PTCA DCB pipeline market are Aachen Resonance GmbH, Acotec Scientific Co Ltd, Advanced Nano Therapies Inc, B. Braun Interventional Systems Inc, Boston Scientific Corp, Caliber Therapeutics, Inc., Chansu Vascular Technologies LLC, Concept Medical Inc, Innova Vascular Inc, and Jiwei Medical System Ltd.

Advanced Nano Therapies Inc: Headquartered in Mountain View, California, the US, Advanced NanoTherapies Inc (Advanced NanoTherapies) is creating nanoparticle technologies that enable and improve drug uptake and retention into the cell for medical devices.

PTCA DCB Pipeline Market Report Overview

Key Territories The US, China, Japan, Europe, and Dominican Republic
Key Regulatory Paths NMPA, PMA, Shonin, 510(k), CE, and de novo
Leading Companies Aachen Resonance GmbH, Acotec Scientific Co Ltd, Advanced Nano Therapies Inc, B. Braun Interventional Systems Inc, Boston Scientific Corp, Caliber Therapeutics, Inc., Chansu Vascular Technologies LLC, Concept Medical Inc, Innova Vascular Inc, and Jiwei Medical System Ltd

Segments Covered in the Report

PTCA DCB Pipeline Market Territories Outlook

  • The US
  • China
  • Japan
  • Europe
  • Dominican Republic

PTCA DCB Pipeline Market Regulatory Paths Outlook

  • NMPA
  • PMA
  • Shonin
  • 510(k)
  • CE
  • de novo

Scope

  • Extensive coverage of the PTCA Drug Coated Balloon (DCB) Catheters under development
  • Reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • Reviews the major players involved in the development of PTCA Drug Coated Balloon (DCB) Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • Provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of PTCA Drug Coated Balloon (DCB) Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Aachen Resonance GmbH
Acotec Scientific Co Ltd
Advanced NanoTherapies Inc
B. Braun Interventional Systems Inc
Boston Scientific Corp
Caliber Therapeutics, Inc.
Chansu Vascular Technologies LLC
Concept Medical Inc
Innova Vascular Inc
Jiwei Medical System Ltd
Lepu Medical Technology (Beijing) Co Ltd
Lifetech Scientific (Shenzhen) Co Ltd
M.A. Med Alliance SA
Medtronic Plc
MicroPort Scientific Corp
OrbusNeich
Orchestra BioMed Inc
QT Vascular Ltd
Rontis Hellas SA
Shanghai MicroPort Medical Group Co Ltd
Shanghai XinZhi Medical Technology Co Ltd
Shenzhen Salubris Pharmaceuticals Co Ltd
Spectranetics Corp
Vascular Nanotransfer Technologies

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 PTCA Drug Coated Balloon (DCB) Catheters Overview

  • 3 Products under Development

    • 3.1 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Stage of Development
    • 3.2 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Territory
    • 3.3 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Regulatory Path
    • 3.4 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Estimated Approval Date
    • 3.5 PTCA Drug Coated Balloon (DCB) Catheters – Ongoing Clinical Trials

  • 4 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products under Development by Companies

    • 4.1 PTCA Drug Coated Balloon (DCB) Catheters Companies – Pipeline Products by Stage of Development
    • 4.2 PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Stage of Development

  • 5 PTCA Drug Coated Balloon (DCB) Catheters Companies and Product Overview

    • 5.1 Aachen Resonance GmbH Company Overview

      • 5.1.1 Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Acotec Scientific Co Ltd Company Overview

      • 5.2.1 Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Advanced NanoTherapies Inc Company Overview

      • 5.3.1 Advanced NanoTherapies Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 B. Braun Interventional Systems Inc Company Overview

      • 5.4.1 B. Braun Interventional Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Boston Scientific Corp Company Overview

      • 5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Caliber Therapeutics, Inc. Company Overview

      • 5.6.1 Caliber Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Chansu Vascular Technologies LLC Company Overview

      • 5.7.1 Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Concept Medical Inc Company Overview

      • 5.8.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Innova Vascular Inc Company Overview

      • 5.9.1 Innova Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Jiwei Medical System Ltd Company Overview

      • 5.10.1 Jiwei Medical System Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Lepu Medical Technology (Beijing) Co Ltd Company Overview

      • 5.11.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 Lifetech Scientific (Shenzhen) Co Ltd Company Overview

      • 5.12.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 M.A. Med Alliance SA Company Overview

      • 5.13.1 M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 Medtronic Plc Company Overview

      • 5.14.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 MicroPort Scientific Corp Company Overview

      • 5.15.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 OrbusNeich Company Overview

      • 5.16.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Orchestra BioMed Inc Company Overview

      • 5.17.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 QT Vascular Ltd Company Overview

      • 5.18.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 Rontis Hellas SA Company Overview

      • 5.19.1 Rontis Hellas SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 Shanghai MicroPort Medical Group Co Ltd Company Overview

      • 5.20.1 Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 Shanghai XinZhi Medical Technology Co Ltd Company Overview

      • 5.21.1 Shanghai XinZhi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview

      • 5.22.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.23 Spectranetics Corp Company Overview

      • 5.23.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.24 Vascular Nanotransfer Technologies Company Overview

      • 5.24.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview

  • 6 PTCA Drug Coated Balloon (DCB) Catheters- Recent Developments

    • 6.1 Apr 12, 2023: Medtronic has a layoff in California
    • 6.2 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
    • 6.3 Feb 06, 2023: Surmodics Lays off 58 employees
    • 6.4 Feb 06, 2023: Surmodics Reports First Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
    • 6.5 Jan 31, 2023: Surmodics to Host Virtual Annual Meeting of Shareholders
    • 6.6 Nov 23, 2022: Medtronic Reports Quarterly Earnings
    • 6.7 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
    • 6.8 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
    • 6.10 Aug 23, 2022: Surmodics to Present at Upcoming Gilmartin Emerging Growth Company Showcase Wednesday, August 31, 2022
    • 6.11 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
    • 6.12 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
    • 6.13 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule
    • 6.14 Jul 28, 2022: Quantum Healthcare Announces Appointment Of Independent Director
    • 6.15 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
    • 6.16 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
    • 6.17 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase

  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us

Table

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Stage of Development 10

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Territory 11

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Regulatory Path 12

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Estimated Approval Date 13

PTCA Drug Coated Balloon (DCB) Catheters – Ongoing Clinical Trials 14

PTCA Drug Coated Balloon (DCB) Catheters Companies – Pipeline Products by Stage of Development 15

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Stage of Development 17

Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview 18

VIAR – Product Status 18

VIAR – Product Description 18

Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

ACOART Sirolimus Coated Balloon Catheter – Product Status 19

ACOART Sirolimus Coated Balloon Catheter – Product Description 19

Acotec Scientific Co Ltd – Ongoing Clinical Trials Overview 20

ACOART Sirolimus Coated Balloon Catheter – A Prospective, Multicenter, Random Controlled Clinical Trail to Evaluate the Effectiveness and Safety of Sirolimus Coated Balloon Versus a Paclitaxel Coated Balloon in the Treatment of Coronary Bifurcation Lesion 21

ACOART Sirolimus Coated Balloon Catheter – A Prospective, Multicenter, Randomized Controlled Trial Comparing the Efficacy and Safety Between Sirolimus Coated Balloon Catheter and Paclitaxel Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis 21

Advanced NanoTherapies Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Sirolimus Coated Angioplasty Balloon – Product Status 22

Sirolimus Coated Angioplasty Balloon – Product Description 22

B. Braun Interventional Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 23

SeQuent Please – Product Status 23

SeQuent Please – Product Description 23

SeQuent Please ReX Drug Coated PTCA Balloon Catheter – Product Status 24

SeQuent Please ReX Drug Coated PTCA Balloon Catheter – Product Description 24

B. Braun Interventional Systems Inc – Ongoing Clinical Trials Overview 25

SeQuent Please – A 2:1 Randomized Trial Comparing the Agent Paclitaxel-coated PTCA Balloon Catheter Versus SeQuent Please Drug Eluting Balloon Catheter for the Treatment of a Small Vessel De Novo Native Coronary Artery Lesion 26

SeQuent Please – A Prospective, Randomized, Non-inferiority Trial to Determine the Safety and Efficacy of the BA9 Drug Coated Balloon for the Treatment of In-stent Restenosis: First-in-man Trial: REFORM 26

SeQuent Please – Comparison of Safety and Efficacy of Coronary Drug-coated Balloon (DCB) Combined with Spot Stenting of Drug-eluting Stent (DES) Versus Second-generation DES for Treating Diffuse Coronary Artery Lesions: A Prospective, Randomized, Controlled Clinical Trial 26

SeQuent Please – Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI 27

SeQuent Please – Drug-coating Balloon Treatment in Coronary Artery Disease: A Prospective, Multicenter, Registry Study (ULTIMATE-DCB) 27

SeQuent Please – Evaluation of the Efficacy and Safety of a Paclitaxel Eluting PTCA Balloon Catheter in Coronary In-stent Restenosis: a Randomized, Open-label, Positive Parallel Controlled, Multicenter Clinical Trial 27

SeQuent Please – To Evaluate the Long Term Safety and Efficacy of Drug Coated Balloon SeQuent Please in Chinese Coronary Instent Restenosis Patients, a Prospective, Multi-center, Randomization Clinical Trial 28

SeQuent Please – Treatment of Coronary De-novo Stenosis by a Sirolimus Coated Balloon or a Paclitaxel Coated Balloon Catheter 28

SeQuent Please ReX Drug Coated PTCA Balloon Catheter – A Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Safety and Efficacy of Paclitaxel Balloon Dilator Versus Paclitaxel Releasing Coronary Balloon Catheter in the Treatment of in Stent Restenosis (ISR) 29

SeQuent Please ReX Drug Coated PTCA Balloon Catheter – U.S. clinical trial of the SeQuent Please ReX Drug Coated PTCA Balloon Catheter 29

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 30

Agent Paclitaxel Coated-PTCA Balloon Catheter – Product Status 30

Agent Paclitaxel Coated-PTCA Balloon Catheter – Product Description 31

Agent Paclitaxel Coated-PTCA Balloon Catheter – Acute Coronary Syndrome – Product Status 31

Agent Paclitaxel Coated-PTCA Balloon Catheter – Acute Coronary Syndrome – Product Description 31

Agent Paclitaxel Coated-PTCA Balloon Catheter – Bifurcations – Product Status 32

Agent Paclitaxel Coated-PTCA Balloon Catheter – Bifurcations – Product Description 32

Agent Paclitaxel Coated-PTCA Balloon Catheter – Small Vessel – Product Status 32

Agent Paclitaxel Coated-PTCA Balloon Catheter – Small Vessel – Product Description 33

Boston Scientific Corp – Ongoing Clinical Trials Overview 34

Agent Paclitaxel Coated-PTCA Balloon Catheter – A 2:1 Randomized Trial Comparing the Agent Paclitaxel-coated PTCA Balloon Catheter Versus SeQuent Please Drug Eluting Balloon Catheter for the Treatment of a Small Vessel De Novo Native Coronary Artery Lesion 35

Agent Paclitaxel Coated-PTCA Balloon Catheter – AGENT IDE: A Prospective, Randomized (2:1), Multicenter Trial to Assess the Safety and Effectiveness of the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects with In-Stent Restenosis (ISR) 35

Agent Paclitaxel Coated-PTCA Balloon Catheter – Intracoronary Stenting and Restenosis – Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5 35

Caliber Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36

TADD Device – Product Status 36

TADD Device – Product Description 36

Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 37

Coronary Everolimus Drug-Coated Balloon – Product Status 37

Coronary Everolimus Drug-Coated Balloon – Product Description 37

Chansu Vascular Technologies LLC – Ongoing Clinical Trials Overview 38

Coronary Everolimus Drug-Coated Balloon – Everolimus-Coated Percutaneous Transluminal Coronary Angioplasty Catheter First in Human Clinical Investigation: A Clinical Evaluation in the Treatment of Subjects with In-Stent Restenosis of Previously-treated Coronary Artery Lesions 39

Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 40

MagicTouch PTCA Balloon Catheter – Product Status 40

MagicTouch PTCA Balloon Catheter – Product Description 40

Concept Medical Inc – Ongoing Clinical Trials Overview 41

MagicTouch PTCA Balloon Catheter – An International, Multicenter, Spontaneous, Randomized Clinical trial of MagicTouch (Sirolimus Coated Balloon) Versus Everolimus Eluting Stent (EES) in Treating Small Coronary Vessel (Transform II) 42

MagicTouch PTCA Balloon Catheter – Evaluate the Performance of a Sirolimus-Eluting Drug-Coated Balloon (SCB) For the Treatment of Any Coronary Lesions, Including De Novo Lesions and In-Stent Restenosis 42

MagicTouch PTCA Balloon Catheter – Magic Touch Sirolimus Coated Balloon (Concept Medical) Versus SeQuent Please Neo Paclitaxel Coated Balloon (Bbraun) for the Treatment of de Novo Coronary Artery Lesions in Small Vessels 42

MagicTouch PTCA Balloon Catheter – Performance of Sirolimus Coated Balloon Catheter System in Treatment of Lesions in Native Coronary Arteries 43

MagicTouch PTCA Balloon Catheter – TicIn for the Treatment of coronAry lesioNs With Drug Eluting Balloons 43

Innova Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Drug Coated Balloon – Product Status 44

Drug Coated Balloon – Product Description 44

Jiwei Medical System Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

Umimus Coated Coronary Artery Balloon Dilatation Catheter – Product Status 45

Umimus Coated Coronary Artery Balloon Dilatation Catheter – Product Description 45

Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

Vesselin Drug Coated Coronary Balloon Catheter – Product Status 46

Vesselin Drug Coated Coronary Balloon Catheter – Product Description 47

Lepu Medical Technology (Beijing) Co Ltd – Ongoing Clinical Trials Overview 48

Vesselin Drug Coated Coronary Balloon Catheter – A Prospective, Multi-center, Randomized Trial Comparing the Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions 49

Vesselin Drug Coated Coronary Balloon Catheter – Assess the Safety and Efficacy of Lepu Drug Coated Balloon Versus Restore Paclitaxel Eluting Balloon for the Treatment of Coronary Small-vessel Disease: A Prospective, Multicenter, Randomized, Controlled Trial 49

Vesselin Drug Coated Coronary Balloon Catheter – Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions: an Open-label, Multicenter, Randomized, Non-inferiority Trial 49

Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

PTCA Drug Eluting Balloon – Product Status 50

PTCA Drug Eluting Balloon – Product Description 50

M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview 51

SELUTION SLR 014 Sirolimus Eluting PTCA Balloon Catheter – Coronary In-Stent Restenosis – Product Status 51

SELUTION SLR 014 Sirolimus Eluting PTCA Balloon Catheter – Coronary In-Stent Restenosis – Product Description 51

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 52

Euphora Drug Coated Balloon – Product Status 52

Euphora Drug Coated Balloon – Product Description 52

Prevail DCB Catheter – Product Status 53

Prevail DCB Catheter – Product Description 53

Medtronic Plc – Ongoing Clinical Trials Overview 54

Prevail DCB Catheter – Drug-Coated Balloon for the Treatment of De Novo and Restenotic Coronary Artery Lesion: a Prospective Observational Study 55

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 56

Rapamycin Drug-Coated Balloon – Product Status 56

Rapamycin Drug-Coated Balloon – Product Description 56

OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 57

Limus Drug Coated Balloon – Coronary – Product Status 57

Limus Drug Coated Balloon – Coronary – Product Description 57

Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview 58

Virtue Sirolimus-Eluting Balloon – ISR – Product Status 58

Virtue Sirolimus-Eluting Balloon – ISR – Product Description 58

Virtue Sirolimus-Eluting Balloon – Small Vessels – Product Status 59

Virtue Sirolimus-Eluting Balloon – Small Vessels – Product Description 59

QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

Chocolate Touch PTCA Coronary Drug Coated Balloon – Product Status 60

Chocolate Touch PTCA Coronary Drug Coated Balloon – Product Description 60

Rontis Hellas SA Pipeline Products & Ongoing Clinical Trials Overview 61

Rontis Drug Coated Balloon – Product Status 61

Rontis Drug Coated Balloon – Product Description 61

Rontis Hellas SA – Ongoing Clinical Trials Overview 62

Rontis Drug Coated Balloon – A Prospective, Multicenter, Single-arm, Pre CE-marking Study Using the Rontis Drug Coated Balloon for Treatment of Lesions in Femoropopliteal Arteries 63

Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

Next-Generation Rapamycin Coronary Balloon Catheter – Product Status 64

Next-Generation Rapamycin Coronary Balloon Catheter – Product Description 64

Shanghai XinZhi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 65

Paclitaxel Coronary Artery Drug Coated Balloon – Product Status 65

Paclitaxel Coronary Artery Drug Coated Balloon – Product Description 65

Rapamycin Coronary Artery Drug Coated Balloon – Product Status 66

Rapamycin Coronary Artery Drug Coated Balloon – Product Description 66

Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 67

Rapamycin Drug-Loaded Coronary ISR Balloon – Product Status 67

Rapamycin Drug-Loaded Coronary ISR Balloon – Product Description 67

Rapamycin Drug-Loaded Coronary LV Balloon – Product Status 68

Rapamycin Drug-Loaded Coronary LV Balloon – Product Description 68

Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 69

Drug Coated Balloon – In-stent Restenosis (ISR) – Product Status 69

Drug Coated Balloon – In-stent Restenosis (ISR) – Product Description 69

Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview 70

Mitomycin-Based DCB – Coronary – Product Status 70

Mitomycin-Based DCB – Coronary – Product Description 70

Paclitaxel-Based Drug Coated Balloon – Coronary – Product Status 71

Paclitaxel-Based Drug Coated Balloon – Coronary – Product Description 71

Glossary 90

Figures

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Stage of Development 10

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Territory 11

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Regulatory Path 12

PTCA Drug Coated Balloon (DCB) Catheters – Pipeline Products by Estimated Approval Date 13

PTCA Drug Coated Balloon (DCB) Catheters – Ongoing Clinical Trials 14

Frequently asked questions

PTCA Drug Coated Balloon (DCB) Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

PTCA Drug Coated Balloon (DCB) Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at PTCA Drug Coated Balloon (DCB) Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live PTCA Drug Coated Balloon (DCB) Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.